Agency for Science, Technology and Research, ImmunID deal

ImmunID partnered with the agency (A*STAR) to use ImmunID’s ImmunTraCkeR and ImmunIG tests to evaluate T and B immune repertoire diversity in the blood of patients enrolled in a clinical trial conducted by A*STAR’s Singapore Immunology Network (SIgN) research unit. ImmunID said the project will last for two years and enroll 180 subjects but is not disclosing the indication and therapeutic intervention being evaluated in the trial. A*STAR said the trial aims to “better understand eroded immunity in the elderly.” The partners declined to disclose financial terms. ...